InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

- Current share price for ARX : $0.520

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$180 Change in substantial holding 27 May 2026 12:23PM $0.625 $0.520 fallen by 16.80%
$180 FY26 Full Year Results Presentation - Correction 26 May 2026 5:03PM $0.620 $0.520 fallen by 16.13%
$180 FY26 Full Year Results Presentation 26 May 2026 8:51AM $0.620 $0.520 fallen by 16.13%
$180 FY26 Appendix 4E and Full Year Results 26 May 2026 8:48AM $0.620 $0.520 fallen by 16.13%
$180 Notification of Full Year Results Webinar 19 May 2026 8:59AM $0.600 $0.520 fallen by 13.33%
$180 ARX FY26 Preliminary Results 30 Apr 2026 8:24AM $0.550 $0.520 fallen by 5.45%
$180 Application for quotation of securities - ARX 10 Apr 2026 3:51PM $0.530 $0.520 fallen by 1.89%
$180 Notification of cessation of securities - ARX 9 Apr 2026 12:34PM $0.530 $0.520 fallen by 1.89%
$180 Symphony Randomised Control Trial Complete 30 Mar 2026 9:15AM $0.570 $0.520 fallen by 8.77%
$180 Release of Shares from Voluntary Escrow 24 Mar 2026 4:27PM $0.580 $0.520 fallen by 10.34%
$180 Application for quotation of securities - ARX 4 Feb 2026 9:47AM $0.695 $0.520 fallen by 25.18%
$180 Eligible NZ Employees Issued with ARX Shares 4 Feb 2026 9:45AM $0.695 $0.520 fallen by 25.18%
$180 AROA Business Update Presentation 3 Feb 2026 8:46AM $0.640 $0.520 fallen by 18.75%
$180 AROA Business Update 3 Feb 2026 8:45AM $0.640 $0.520 fallen by 18.75%
$180 Notification of Investor Webinar 27 Jan 2026 10:57AM $0.720 $0.520 fallen by 27.78%
$180 Study Demonstrates Effectiveness & Economic Value of Myriad 22 Jan 2026 2:30PM $0.725 $0.520 fallen by 28.28%
$180 Notification of cessation of securities - ARX 9 Jan 2026 10:18AM $0.755 $0.520 fallen by 31.13%
$180 Symphony Outpatient Reimbursement Update 19 Dec 2025 9:24AM $0.650 $0.520 fallen by 20%
$180 Aroa Half Year Results Presentation 25 Nov 2025 8:50AM $0.685 $0.520 fallen by 24.09%
$180 Aroa Biosurgery H1 FY26 Results 25 Nov 2025 8:36AM $0.685 $0.520 fallen by 24.09%
$180 Appendix 4D and Half Year Report 25 Nov 2025 8:35AM $0.685 $0.520 fallen by 24.09%
$180 Notification regarding unquoted securities - ARX 12 Nov 2025 12:11PM $0.770 $0.520 fallen by 32.47%
$180 Aroa Biosurgery H1 Results Webinar & Investor Event 11 Nov 2025 12:42PM $0.780 $0.520 fallen by 33.33%
$180 Initial Director's Interest Notice - PS 3 Nov 2025 4:14PM $0.795 $0.520 fallen by 34.59%
$180 Final Director's Interest Notice - JP 3 Nov 2025 4:12PM $0.795 $0.520 fallen by 34.59%

26 - 50 of 770 results

Page 2 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.